{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:41:43Z","timestamp":1759405303521,"version":"build-2065373602"},"reference-count":52,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.vaccine.2022.10.009","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T07:13:40Z","timestamp":1665990820000},"page":"7087-7096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["A retrospective evaluation of side\u2010effects associated with the booster dose of Pfizer-BioNTech\/BNT162b2 COVID\u201019 vaccine among females in Eastern Province, Saudi Arabia"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-5849","authenticated-orcid":false,"given":"Yousif A.M.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3752-2331","authenticated-orcid":false,"given":"Mohammad","family":"Daud Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan Rashad","family":"Al-Eid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatimah Ali","family":"Al-Ghuraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zainab","family":"Essa Alqasimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3137-637X","authenticated-orcid":false,"given":"Ayaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8944-6831","authenticated-orcid":false,"given":"Zainab","family":"Eltrafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4423-0126","authenticated-orcid":false,"given":"Sherihan Ahmad","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"WHO. Global coronavirus statistics. United Nations. Published 2021. Available from: https:\/\/covid19.who.int\/region\/amro\/country\/us .(Assess on 14th March 2022).","key":"10.1016\/j.vaccine.2022.10.009_b0005"},{"unstructured":"Coronavirus Cases: Reported Cases and Deaths by Country or Territory. Available from: https:\/\/www.worldometers.info\/coronavirus\/#countries .(Assess on 14th March 2022).","key":"10.1016\/j.vaccine.2022.10.009_b0010"},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.009_b0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/wound.2020.1309","article-title":"Cutaneous Manifestations of COVID-19: A Systematic Review","volume":"10","author":"Singh","year":"2021","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.009_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/ane.13266","article-title":"Neurological Manifestations of COVID-19: A systematic review and current update","volume":"142","author":"Whittaker","year":"2020","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.vaccine.2022.10.009_b0025","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/jcm10040581","article-title":"Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases","volume":"10","author":"Hockov\u00e1","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.vaccine.2022.10.009_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104210","article-title":"A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence","volume":"130","author":"Suri","year":"2021","journal-title":"Comput Biol Med"},{"issue":"7844","key":"10.1016\/j.vaccine.2022.10.009_b0035","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1038\/s41586-020-03098-3","article-title":"Publisher correction: phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"590","author":"Mulligan","year":"2021","journal-title":"Nature"},{"unstructured":"FDA. Published 2021 Updated 2021 Aug 23. [Updated on 11th March 2022]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-covid-19-vaccine . (Assess on 14th March 2022).","key":"10.1016\/j.vaccine.2022.10.009_b0040"},{"issue":"27","key":"10.1016\/j.vaccine.2022.10.009_b0045","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.10.009_b0050","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/vaccines9030226","article-title":"Acceptability of a COVID-19 Vaccine among the Saudi Population","volume":"9","author":"Alfageeh","year":"2021","journal-title":"Vaccines"},{"unstructured":"Background document on the mRNA vaccine BNT162b2 (Pfizer-BioNTech) against COVID-19. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/338671\/WHO-2019-nCoV-vaccines-SAGE_recommendation-BNT162b2-background-2021.1-eng.pdf?sequence=1&isAllowed=y . (Assess on 14th March 2022).","key":"10.1016\/j.vaccine.2022.10.009_b0055"},{"unstructured":"Interim statement on booster doses for COVID-19 vaccination. Available from: https:\/\/www.who.int\/news\/item\/22-12-2021-interim-statement-on-booster-doses-for-covid-19-vaccination---update-22-december-2021 . (Assess on 14th March 2022).","key":"10.1016\/j.vaccine.2022.10.009_b0060"},{"issue":"6","key":"10.1016\/j.vaccine.2022.10.009_b0065","first-page":"645","article-title":"Menopausal symptoms and quality of life among Saudi women visiting primary care clinics in Riyadh","volume":"7","author":"AlDughaither","year":"2015","journal-title":"Saudi Arabia Int J Womens Health"},{"issue":"24","key":"10.1016\/j.vaccine.2022.10.009_b0070","doi-asserted-by":"crossref","first-page":"13373","DOI":"10.3390\/ijerph182413373","article-title":"COVID-19 Vaccine Acceptance of Pregnant and Lactating Women (PLW) in Czechia: An Analytical Cross-Sectional Study","volume":"18","author":"Riad","year":"2021","journal-title":"Int J Environ Res Public Health"},{"unstructured":"Saudi Food & Drug Authority Allows the Import and Use of Pfizer-BioNTech (BNT162b2) Covid19 Vaccine. Available from: https:\/\/sfda.gov.sa\/en\/cnews . (Assess on 14th March 2022).","key":"10.1016\/j.vaccine.2022.10.009_b0075"},{"issue":"12","key":"10.1016\/j.vaccine.2022.10.009_b0080","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","volume":"385","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.10.009_b0085","volume":"2021","author":"Ossato","year":"2021","journal-title":"Eur J Hosp Pharm"},{"issue":"8","key":"10.1016\/j.vaccine.2022.10.009_b0090","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41591-021-01454-y","article-title":"COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries","volume":"27","author":"Arce","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2022.10.009_b0095","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.jaip.2020.12.047","article-title":"mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: Current evidence and suggested approach","volume":"9","author":"Banerji","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"unstructured":"Raosoft sample size calculator. Available from: http:\/\/www.raosoft.com\/samplesize.html . (Assess on 14\/03\/2022).","key":"10.1016\/j.vaccine.2022.10.009_b0100"},{"issue":"6","key":"10.1016\/j.vaccine.2022.10.009_b0105","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/vaccines9060556","article-title":"Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects","volume":"9","author":"Hatmal","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.vaccine.2022.10.009_b0110","doi-asserted-by":"crossref","first-page":"e14605","DOI":"10.1111\/ijcp.14605","article-title":"Adverse reactions to Pfizer-BioNTech vaccination of healthcare workers at Malta\u2019s state hospital","volume":"75","author":"Cuschieri","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.009_b0115","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaci.2021.05.029","article-title":"Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity","volume":"148","author":"Hagin","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2022.10.009_b0120","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3390\/vaccines9060553","article-title":"Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals","volume":"9","author":"Nittner-Marszalska","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2022.10.009_b0125","first-page":"46","article-title":"Comparison of stopping rules in forward \u201cstepwise\u201d regression","volume":"72","author":"Bendel","year":"1977","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.vaccine.2022.10.009_b0130","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"issue":"5","key":"10.1016\/j.vaccine.2022.10.009_b0135","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines9050515","article-title":"Factors affecting COVID-19 vaccine acceptance: An international survey among Low- and Middle-Income Countries","volume":"9","author":"Bono","year":"2021","journal-title":"Vaccines"},{"unstructured":"Available online: Covid vaccine: Period changes could be a short-term side effect. https:\/\/www.bbc.com\/news\/health-56901353. (Access on 5th Dec. 2021).","key":"10.1016\/j.vaccine.2022.10.009_b0140"},{"issue":"5","key":"10.1016\/j.vaccine.2022.10.009_b0145","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3390\/ph14050406","article-title":"COVID-19 Vaccines: a review of the safety and efficacy of current clinical trials","volume":"14","author":"Yan","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"24","key":"10.1016\/j.vaccine.2022.10.009_b0150","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","article-title":"Preliminary findings of mRNA Covid-19 vaccine safety in Pregnant persons","volume":"384","author":"Shimabukuro","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2022.10.009_b0155","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3390\/vaccines9060674","article-title":"Evaluation of Side-effects Associated with COVID-19 Vaccines in Saudi Arabia","volume":"9","author":"Alhazmi","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2022.10.009_b0160","first-page":"131","article-title":"Perceptions and Experiences of COVID-19 Vaccine Side-Effects Among Healthcare Workers in Southern Ethiopia: A Cross-Sectional Study","volume":"12","author":"Zewude","year":"2021","journal-title":"Pragmat Obs Res"},{"issue":"16","key":"10.1016\/j.vaccine.2022.10.009_b0165","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMc2036242","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"384","author":"Skowronski","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2022.10.009_b0170","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/AOG.0000000000004695","article-title":"Association Between Menstrual Cycle Length and Coronavirus Disease 2019 (COVID-19) Vaccination: A U.S","volume":"139","author":"Delman","year":"2022","journal-title":"Cohort Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2022.10.009_b0175","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-cellbio-100616-060718","article-title":"Sex and gender differences in the outcomes of vaccination over the life course","volume":"33","author":"Flanagan","year":"2017","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.10.009_b0180","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000519456","article-title":"Adverse events following AstraZeneca COVID-19 vaccine in Saudi Arabia: A cross-sectional study among healthcare and non-healthcare workers","volume":"65","author":"Alghamdi","year":"2022","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2022.10.009_b0185","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2147\/PPA.S330689","article-title":"Evaluation of post-vaccination symptoms of two common COVID-19 vaccines used in Abha, Aseer Region, Kingdom of Saudi Arabia","volume":"15","author":"Adam","year":"2021","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"10.1016\/j.vaccine.2022.10.009_b0190","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2107456","article-title":"Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents","volume":"385","author":"Frenck","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.10.009_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103401","article-title":"SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors","volume":"68","author":"Frieman","year":"2021","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.vaccine.2022.10.009_b0200","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID symptom study app in the UK: A prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2022.10.009_b0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jogn.2020.08.001","article-title":"Sex-based vaccine response in the context of COVID-19","volume":"49","author":"McCartney","year":"2020","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"10.1016\/j.vaccine.2022.10.009_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2021.761511","article-title":"Sex and gender in COVID-19 vaccine research: Substantial evidence gaps remain","volume":"2","author":"Vassallo","year":"2021","journal-title":"Front Glob Women Health"},{"key":"10.1016\/j.vaccine.2022.10.009_b0215","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.vaccine.2017.03.035","article-title":"Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012\u20132015","volume":"35","author":"Harris","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2022.10.009_b0220","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/vaccines9060577","article-title":"Side-effects reported by Jordanian healthcare workers who received COVID-19 vaccines","volume":"9","author":"Abu-Hammad","year":"2021","journal-title":"Vaccines"},{"issue":"8","key":"10.1016\/j.vaccine.2022.10.009_b0225","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/biology10080752","article-title":"Side-effects of mRNA-based and viral vector-based COVID-19 vaccines among German healthcare workers","volume":"10","author":"Klugar","year":"2021","journal-title":"Biology"},{"issue":"9","key":"10.1016\/j.vaccine.2022.10.009_b0230","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/ph14090873","article-title":"Side-effects of mRNA-based COVID-19 vaccine: Nationwide phase IV study among healthcare workers in Slovakia","volume":"14","author":"Riad","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.vaccine.2022.10.009_b0235","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3390\/vaccines9101096","article-title":"Adverse events following immunization associated with the first and second doses of the ChAdOx1 nCoV-19 vaccine among healthcare workers in Korea","volume":"9","author":"Jeon","year":"2021","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.009_b0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/AOG.0000000000004636","article-title":"Scientific evidence supporting coronavirus disease 2019 (COVID-19) vaccine efficacy and safety in people planning to conceive or who are pregnant or lactating","volume":"139","author":"Girardi","year":"2022","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.009_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1999.79.1.1","article-title":"Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action","volume":"79","author":"Turnbull","year":"1999","journal-title":"Physiol Rev"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.009_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67668-1","article-title":"Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: Data mining of Vaccine Adverse Event Reporting System","volume":"10","author":"Gong","year":"2020","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.vaccine.2022.10.009_b0255","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1001\/jamacardio.2021.3471","article-title":"Association of myocarditis with BNT162b2 messenger RNA COVID-19 Vaccine in a case series of children","volume":"6","author":"Dionne","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.vaccine.2022.10.009_b0260","doi-asserted-by":"crossref","first-page":"e2022023","DOI":"10.4084\/MJHID.2022.023","article-title":"Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation","volume":"14","author":"Ucciferri","year":"2022","journal-title":"Mediterr J Hematol Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22012579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:19:50Z","timestamp":1759403990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22012579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":52,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0264410X22012579"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.009","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective evaluation of side\u2010effects associated with the booster dose of Pfizer-BioNTech\/BNT162b2 COVID\u201019 vaccine among females in Eastern Province, Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}